Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to ...

Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...

Researchers at Moffitt Cancer Center have found that tapping into the body’s own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of ...

A woman fighting Stage 4 lung cancer becomes a U.S. citizen at a Tulsa Naturalization Ceremony. It comes after a more than a ...

When Paul Hall was diagnosed with stage 4 lung cancer in October 2021, he said, “I’m not quitting.” ...

Researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy -- opening a new path for lung ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Biomarker testing in advanced NSCLC has increased in recent years, but turnaround time has remained roughly the same, data suggest.

From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

A gene once believed to be extremely rare may actually be surprisingly common—and capable of quietly raising the risk of ...